November 20, 2007   Pam Abramowitz

Here are the top U.S. analysts who have adapted their research coverage to help hedge funds generate alpha.

ON MAY 10, 2007, the U.S. Food and Drug Administration held a nine-hour meeting over potential labeling changes for Aranesp, Amgen's best-selling drug, used to treat chemotherapy-induced anemia. Restrictions could annihilate sales at the Thousand Oaks, California­based biotechnology giant. Early …


Subscribers have unlimited access to all online content inc rankings. Start your subscription today - click on the button below.

Subscribe now

Free trial

Taking a free trial will give you access to online content one week (excludes research & rankings). Start your trial today.

Free Trial

Latest Poll

Will the Federal Reserve raise interest rates this year?

 - 0%
 - 52%
 - 48%

View previous results